Viewing Study NCT01815359


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-01-25 @ 3:56 AM
Study NCT ID: NCT01815359
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-04
First Post: 2013-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-03
Start Date Type: None
Primary Completion Date: 2026-09
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-09
Completion Date Type: ESTIMATED
First Submit Date: 2013-03-13
First Submit QC Date: None
Study First Post Date: 2013-03-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-03
Last Update Post Date: 2025-02-04
Last Update Post Date Type: ACTUAL